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!. The enzyme nitric oxide synthase is present in the
macula densa and may participate in the control of
renin secretion by the adjacent juxtaglomerular cells.
in the present study, we investigated the effect of
inhibiting nitric oxide synthase on the renin secretory
response to frusemide, which stimulates renin secre-
tion by blocking Na+-K÷-2CI - co-transport in the
macula densa.
2. Injection of frusemide in 12 conscious rabbits
elicited a transient increase in mean arterial pressure
from 84+2 to 92-1-3mmHg at 5min (P<0.01) and
a sustained increase in heart rate from 246_+6 to
281 + 10 beats/rain at 45rain (P<0.01). Plasma renin
activity increased from 8.0__.1.2 to 14.3-1-1.8,
12.4_+1.6 and ll.6_+l.5pmol2h-_ml -_ at 15, 30
and 45rain respectively (P<0.01). There were no
changes in plasma sodium and potassium concen-
trations or osmolality.
3. Inhibition of nitric oxide synthase with N_-nitro-L -
arginine methyl ester increased mean arterial pres-
sure by 9mmHg, decreased heart rate and plasma
renin activity, and markedly suppressed the renin
response to frusemide (from 4.6_+0.7 to 7.6_+1.7,
4.7-1-1.0 and 4.6-1-0.7pmol2h-iml -I at 15, 30 and
45rain respectively). By contrast, infusion of an
equipressor dose of phenylephrine did not suppress the
renin response to frusemide.
4. Histochemical studies with the NADPH diaphor-
ase technique confirmed the presence of nitric oxide
synthase in the macula densa, and suggested that
enzyme activity is increased by treatment with
frusemide.
5. These results are consistent with a role for the L-
arginine-nitric oxide pathway in the modulation of
renin secretion by the macula densa.
INTRODUCTION
Anatomical and functional studies have estab-
lished that the macula densa plays an important
role in the regulation of renin secretion [I-5].
Specifically, there is evidence that the macula densa
functions as a sodium/chloride sensor by a mecha-
nism involving an Na+-K+-2CI co-transporter in
the luminal membrane of the macula densa cells
[5-7]. Alterations in Na+-K+-2C1 co-transport
result in inverse changes in renin secretion by the
adjacent juxtaglomerular cells [8].
One of the least understood aspects of this
macula densa control of renin secretion is how the
cells of the macula densa communicate with the
juxtaglomerular cells. Several mediators have been
proposed, including adenosine and prostacyclin [5,
9, 10]. Nitric oxide may also play a role. This
proposal is based primarily on the findings that the
macula densa contains a high concentration of the
enzyme nitric oxide synthase [11-13] and that
arginine analogues which inhibit nitric oxide syn-
thase alter the rate of renin secretion [14-19].
The aim of the present investigation was to test
the hypothesis that the L-arginine-nitric oxide path-
way participates in the control of renin secretion by
the macula densa. Experiments were performed in
conscious rabbits to determine if inhibition of nitric
oxide synthesis alters the renin secretory response to
frusemide, a diuretic that stimulates renin secretion
by, at least in part, inhibiting Na+-K+-2CI co-
transport in the macula densa [20, 21]. In addition,
the NADPH diaphorase histochemical technique
was used to determine if acute administration of
frusemide alters nitric oxide synthase activity in the
macula densa.
METHODS
The experiments were performed on male New
Zealand White rabbits weighing 2.5-3.5 kg (Nitabell
Rabbitry, Hayward, CA, U.S.A.). The rabbits were
housed in separate cages in a 12h light-cycled and
temperature-controlled room. They were fed a com-
mercial diet (Purina rabbit chow, Ralston-Purina,
St. Louis, MO, U.S.A.) and were provided with
water ad libitum. Surgical and experimental
procedures were approved by the University of
California, San Francisco Committee on Animal
Research.
Surgical preparation
Surgical procedures were performed under aseptic
Key words: frusemide,nitric oxide, NG-nitro-c-arginine methyl ester, maculadensa, renin release.
Abbreviations: HR, heart rate; c-NAME, NG-nitro-c-arginine methyl ester; MAP, mean arterial pressure;PRA, plasmarenin activity.
Correspondence: Dr tan A. Reid, Department of Physiology, Universityof California, SanFrancisco,San Francisco,CA 94143-0444,U.S.A.
https://ntrs.nasa.gov/search.jsp?R=19980211649 2020-06-16T00:07:24+00:00Z
658 I.A. ReidandL. Chou
conditions during anaesthesia with intramuscular
ketamine (35-50mg/kg; Parke-Davis, Morris Plains,
N J, U.S.A.) and xylazine (5-10mg/kg; Lloyd Labor-
atories, Shenandoah, IA, U.S.A.). A catheter consist-
ing of 10cm of medical-grade Silastic (0.76 mm inner
diameter, 1.65mm outer diameter; Dow-Corning
Corp., Midland, MI, U.S.A.) connected to PE60
tubing was inserted into a femoral artery and
advanced into the aorta to a point distal to the
kidneys. Two Tygon catheters (0.76ram inner dia-
meter, 1.27mm outer diameter) were inserted into a
jugular vein and positioned near the heart. The
three catheters were led subcutaneously to a point
between the scapulae, where they emerged through
a small skin incision, and were protected in a
pocket of a nylon mesh jacket. The rabbits were
allowed to recover for at least 3 days after surgery,
during which time they were treated with intrave-
nous ampicillin (10rag/day; Sigma, Chemical Co., St
Louis, MO, U.S.A.). The catheters were flushed with
sterile heparinized isotonic saline (100units/ml) at
least every other day. During the recovery period,
the rabbits were brought to the laboratory and
accustomed to the experimental environment.
Experimental protocols
On the day of an experiment, a rabbit was
brought to the laboratory, where it rested comfort-
ably in a partly covered cage. Arterial blood pres-
sure and heart rate were continuously monitored
using a pressure transducer (Cobe Laboratories,
Lakewood, CO, U.S.A.) and a custom-built cardio-
vascular analyser. The cardiovascular data were
simultaneously recorded on a Grass polygraph, and
digitized, stored and analysed using a PDP 11/
23+computer (Digital Equipment Corporation,
Maynard, MA, U.S.A.). Blood samples (volume=
1.2ml) for analysis were collected from the femoral
arterial catheter and replaced with an equal volume
of sterile isotonic NaCI. We have previously
observed that the volume of blood removed during
the course of these experiments does not change the
haematocrit. Experiments were begun when blood
pressure and heart rate had remained stable at their
basal values for at least 15min. The experiments
were performed according to the following protocols.
Effect of inhibition of nitric oxide synthesis on the
renin and cardiovascular responses to frusemide. In
12 rabbits, blood pressure and heart rate were
monitored during a 15-min control period, at the
end of which a blood sample was collected. An
intravenous infusion of 0.9_o saline at 0.02ml/min
was then started and continued for the duration of
the experiment. Fifteen minutes after the start of the
saline infusion, another blood sample was collected.
Frusemide (American Regent Laboratories, Shirley,
NY, U.S.A.) was then injected intravenously in a
single dose of 2.0mg/kg. Blood samples were
collected 15, 30, and 45min after frusemide admi-
nistration. This procedure was repeated in the same
rabbits on the following day, but the saline infusion
was replaced with an intravenous infusion of the
nitric oxide synthase inhibitor NG-nitro-L-arginine
methyl ester hydrochloride (L-NAME, Sigma) [22,
23] at 0.5mgmin-tkg _. On the third day, the
effect of frusemide in the presence of isotonic saline
was tested again.
Effect of phenylephrine on the renin and cardiovas-
cular responses to frusemide. The aim of this experi-
ment was to investigate the possibility that L-
NAME might alter the renin response to frusemide
by increasing blood pressure. In nine rabbits, the
effects of frusemide were tested as described in the
protocol above, but the L-NAME infusion on day 2
was replaced with an intravenous infusion of pheny-
lephrine (Neo-Synephrine, Winthrop, NY, U.S.A.).
The dose of phenylephrine was adjusted between 0.5
and 2.0/_gmin -1 kg t in order to produce the same
increase in blood pressure as that produced by
L-NAME.
NADPH diaphorase histochemistry. Rabbits
received an intravenous injection of isotonic saline
(2ml, n=3) or frusemide (10mg/kg, n=3). Thirty
minutes later the rabbits were anaesthetized with
sodium pentobarbital (30mg/kg) and the kidneys
rapidly removed. Blocks of renal cortex were fixed
for 4h in phosphate buffer (pH 8.0) containing 2'Yo
formaldehyde and 0.002_ picric acid, immersed in
15'_,; sucrose for 24h and frozen. Tissue sections of
7/_m were cut in a cryostat, placed on charged glass
slides, and dried. The sections were incubated at
37"C for 60-90min in phosphate buffer (pH8.0)
containing NADPH (1 mg/ml), nitroblue tetrazolium
(0.1 mg/ml) and 0.2_ o Triton X-100. The sections
were then rinsed, mounted in glycerol and examined
by light microscopy.
Analytical methods
Plasma renin activity (PRA) was measured using
a radioimmunoassay for angiotensin I and expressed
as pmol of angiotensin I generated per ml of plasma
during a 2-h incubation at 37°C and pH6.5
(pmol2h -1 ml _) [24]. Plasma sodium and potas-
sium concentrations were measured by flame photo-
metry and plasma osmolality by freezing point
depression.
Statistical analysis
Results are expressed as the means+SEM. Data
were analysed using analysis of variance for
repeated measures followed by the Neuman Keuls
or Dunnett test [25]. Changes were considered to
be statistically significant when P<0.05.
RESULTS
Effect of inhibition of nitric oxide synthesison the renin
and cardiovascular responses to frusemide
The effects of frusemide and L-NAME on blood
pressure, heart rate and plasma renin activity are
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Fig. I. Effectsof frusemideon mean arterial pressure(MAP), heart
rate (HR) and plasmarenin activity (PRA) duringinfusionof saline
vehicleor L-NAME. Infusionof L-NAMEor salinewasstartedimme-
diatelyafter completionof control measurementsat -15rain andconti-
nued throughout the experimentas indicatedby the horizontal bar.
Frusemidewasinjectedat 0 rainasindicatedbythearrow.Valuesrepresent
the means+ SEMof observationsmadein 12 rabbits.Previouslyreported
data[14]showingthe effectsof L-NAMEwithout frusemidearealsoshown.
_P<0.05, +'P<0.01 comparedwith 15minvalue.*P<0.05. **P<
0,01comparedwith 0min value.O, Salinel'frusemide;O, L-NAME__fruse-
mide;A,, L-NAHE:_saline
summarized in Fig. l. Injection of frusemide eli-
cited a transient increase in mean arterial pressure
(MAPt from 84+2 to 92_+3mmHg at 5min
(P <0.01t, and increased heart rate (HR) from 246_+6
to 281_+10 beats/min at 45min (P<0.01). PRA
increased from 8.0_+ 1.2 to 14.3_+ 1.8pmol2h _ml
15min after the injection and remained elevated
for the next 30min. Administration of frusemide
did not change plasma sodium (142_+0.4 to 143+
0.4mmol/lt or potassium (4.2_+0.1 to 4.1-+0.1
mmol/l) concentrations, or osmolality (289_+1 to
288-+lmosmol/kgH20). On the following day,
infusion of L-NAME increased MAP from 74+2 to
83-+2mmHg (P<0.01), decreased HR from 238+8
to 215+8beats/min (P<0.01) and decreased PRA
from 7.3_+0.9 to 4.6+0.7pmo12h _ml _ after
15min (P<0.01). L-NAME markedly reduced the
renin response to subsequent administration of
frusemide. Thus, while frusemide alone increased
PRA by 6.3, 4.4 and 3.6pmo12h a ml _ at 15, 30
and 45 min respectively, frusemide in the presence of
L-NAME increased it by only 3.0, 0.1 and
0pmol2h 'ml 1. Treatment with L-NAME also
prolonged the pressor response to frusemide and
inhibited the H R response.
Previously reported data i-14] showing the effects
of L-NAME without frusemide are also shown in
Fig. 1. It can be seen that the maximum cardiovas-
cular and renin responses to this dose of L-NAME
occur during the first 15min of the L-NAME
infusion.
Administration of frusemide on the third day
produced changes in MAP 183.4+4.9 to 88.5_+
3.9mmHg at 5min), HR (198+6 to 257-+11 beats/
min at 45rain) and PRA (5.6_+1.2 to 12.4_+3.8
pmol2h _ml ' at 15min) that were not signifi-
cantly different from those on the first day.
Effect of phenylephrine on the renin and cardiovascular
responses to frusemide
The effect of phenylephrine on the renin and
cardiovascular responses to frusemide are sum-
marized in Fig. 2. Frusemide alone increased PRA
from 4.9_+1.0 to 9.3_+l.3pmo12h _ml _ at 15rain
(P < 0.01 I. Infusion of phenylephrine increased MAP
from 73_+3 to 82-+4mmHg tP<0.011 (an increase
identical to that produced by L-NAME) and
decreased PRA from 5.1 +0.7 to 2.6_+
0.5pmol2h _ml ' (P<0.05). However, in contrast
to L-NAME, phenylephrine did not reduce the
subsequent PRA response to frusemide (to 7.3+_
1.9pmol2h 'ml _ at 15min, P<0.05j, although
the response was more variable in the presence of
phenylephrine. The MAP and HR responses to
frusemide were also unaltered by phenylephrine.
NADPH diaphorase histochemistry
NADPH diaphorase staining was observed in
macula densas of kidneys from control rabbits and
from rabbits treated with frusemide. Representative
sections of renal cortex from two control and two
frusemide-treated rabbits are shown in Fig. 3. Stain-
ing of the macula densa was generally more intense
in frusemide-treated rabbits than in control rabbits.
However, quantitation of the staining intensity is
required before firm conclusions can be made con-
cerning the effect of frusemide.
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Fig.2, Effectsoffrusemideonmeanarterialpressure(MAP),heart
rate (HR)andplasmareninactivity(PRA)duringinfusionofsaline
vehicle(O) orphenylephrlne(O). Infusionof phenylephrineorsaline
wasstartedimmediatelyaftercompletionof controlmeasurementsa
-15min andcontinuedthroughouthe experiment.Frusemidewas
injectedat0rain.Valuesrepresentthemeans_+SEHofobservationsmade
in ninerabbits.÷P<0.05comparedwith -J5min value.*P<0.05,
**P< 0.01comparedwith0rainvalue.
DISCUSSION
The aim of this investigation was to determine if
nitric oxide participates in macula densa-mediated
control of renin secretion. In order to do this, it was
necessary to identify a stimulus to renin secretion
that operates specifically through the macula densa
mechanism. This is difficult because many stimuli
which are believed to activate the macula densa
mechanism, e.g. sodium deficiency, haemorrhage and
decreased renal perfusion pressure, also activate the
renal baroreceptor and/or extrarenal mechanisms
controlling renin secretion [!. 2, 43.
One exception is administration of frusemide.
Although this diuretic has multiple and complex
effects on renin secretion when administered chroni-
cally [2], it appears to stimulate renin secretion by
a direct action on the macula densa when adminis-
tered acutely [21, 26, 27, 30]. Thus, in the present
experiments, the maximum renin response to fruse-
mide occurred at 15min, at which time volume
depletion would have been insignificant. Other
investigators have reported that frusemide increases
renin secretion when urinary losses are prevented
[26, 27]. Blood pressure increased transiently
following frusemide administration, and this would
be expected to decrease, rather than increase, renin
secretion [1, 2]. Plasma sodium and potassium
concentrations and osmolality did not change.
Frusemide has been reported to increase renal sym-
pathetic nerve activity in rats [28] and plasma
noradrenaline concentration in dogs [29], but the
renin secretory response to acute administration of
frusemide is not blocked by fi-adrenoceptor block-
ade [27, 30], suggesting that it is not mediated by
the sympathetic nervous system. Moreover, in pre-
liminary experiments we observed that frusemide
does not increase renal sympathetic nerve activity
in conscious rabbits (K. Kumagai and I. A. Reid,
unpublished work). Finally, frusemide stimulates
renin secretion by microdissected afferent arterioles
with the macula densa attached, but not from
microdissected afferent arterioles alone [21]. Thus,
the stimulation of renin secretion by frusemide
in the present study was probably mediated by
the macula densa. Recent evidence indicates that
this stimulation results from inhibition of
Na+-K+-2C[ co-transport in the macula densa
[5 8, 20].
It has been reported that the macula densa
contains a high level of nitric oxide synthase as
detected by immunocytochemistry and NADPH
diaphorase histochemisty [11-13], and this was
confirmed in the present study. Furthermore, it has
been suggested that nitric oxide originating in the
macula densa participates in the control of renin
secretion [11, 12]; indeed, it may be an important
chemical mediator between the macula densa and
the juxtaglomerular cells. In order to test this
possibility, we investigated the effect of inhibiting
nitric oxide synthase on the renin response to
frusemide. L-NAME decreased resting PRA and
markedly suppressed the renin response to fruse-
mide. Before L-NAME, there were significant
increases in PRA 15, 30 and 45 min after frusemide;
after L-NAME, there was only a small, transient
increase at 15 min.
It is important to note that L-NAME was admi-
nistered systemically in the present study so that
blockade of nitric oxide synthase was not limited to
the kidney. Thus, the possibility must be considered
that the inhibitory effect of L-NAME on the renin
response to frusemide was a consequence of inhibi-
tion of extrarenal nitric oxide synthase, in particular
Nitric oxideandreninsecretion
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Fig.3.NADPHhistochemistryof sectionsofkidneysfromtwocontrolrabbits(top)andtwofrusemide-treatedrabbits(bottom).G,glomerulus;MD,
maculadensa;PT,proximaltubule;DT,distaltubule.
the increase in blood pressure. However, infusion of
an equipressor dose of phenylephrine did not inhibit
the renin response to frusemide, and it therefore
seems reasonable to suggest that L-NAME inhibits
the renin response to frusemide by blocking nitric
oxide synthesis within the kidney. Nevertheless, it is
difficult to rule out the systemic effects of blockade
of nitric oxide synthesis, and additional studies with
intrarenal infusion of L-NAME are needed to rest
this proposal more directly.
How could nitric oxide translate changes in macula
densa Na+-K+-2CI transport into changes in
renin secretion'? Specifically, does Na+-K+-2CI
transport affect macula densa nitric oxide synthase
activity, and what effect does nitric oxide have on
renin secretion'? At present, there is no clear answer
to either question, but the following is presented as
a working hypothe.sis. First, it is proposed that
nitric oxide originating in the macula densa diffuses
into the adjacent juxtaglomerular cells. Here it
could incrcase cyclic GMP concentration, which in
turn could stimulate renin secretion, possibly by
decreasing the intracellular concentration of calcium
[4, 31]. In support of this proposal are reports that
blockade of nitric oxide synthase decreases renal
cyclic GMP lcvcls [32] and inhibits renin secretion
in vitro and in t_it_o [14-19]. Second, it is proposed
that Na+-K+-2CI co-transport by the macula
densa decreases calcium concentration in cells of
the macula densa and, as a result, decreases nitric
oxide synthase activity and nitric oxide formation.
Blocking Na ÷ K -_ 2C1 co-transport with fruse-
mide would increase nitric oxide synthase activity
(as the results of the present histochemical study
suggest)_ resulting in an increase in renin secretion
which would be prevented by L-NAME (as was
observed in the present study). According to this
scheme, it would be predicted that the renin re-
sponse to a reduction in the delivery of sodium
chloride to the macula densa would also be blocked
by inhibition of nitric oxide synthase. Recent studies
by He et al. [-33] using a perfused juxtaglomerular
apparatus preparation have shown this to be the
case.
Several key questions concerning this hypothesis
remain to be resolved. In particular, there is, to our
knowledge, no direct evidence that Na÷-K + 2CI
co-transport by the macula densa inhibits nitric
oxide synthase activity. However, nitric oxide syn-
thase requires calcium for enzyme activity [34, 35],
and it has been reported that perfusion of the
macula densa with a low concentration of sodium
chloride increases cytosolic free calcium concen-
tration in macula densa cells [36]. Thus, it would be
anticipated that Na÷-K*-2C1 co-transport by the
macula densa would decrease calcium concentration
and suppress nitric oxide synthase activity.
Although negative results have been obtained [36],
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frusemide has been reported to increase calcium
levels in the kidney [37], and this would be
expected to increase nitric oxide synthase activity.
Our observation that frusemide increases NADPH
diaphorase staining in the macula densa is consis-
tent with such an action. Another problem is that,
although some studies indicate that cyclic GMP
stimulates renin secretion, others suggest that it
inhibits or has no effect [4, 31, 38-42].
It is important to acknowledge that, although our
results are consistent with a role for nitric oxide in
the macula densa control of renin secretion, they by
no means prove it. It is possible, for example, that
the action of L-NAME in suppressing the renin
secretory response to frusemide results from block-
ade of nitric oxide synthesis in cells other than those
of the macula densa, such as mesangial [-43],
endothelial or other cells. A systemic effect of L-
NAME also cannot be ruled out, although the
present results suggest that changes in blood pres-
sure are not responsible. Finally, even if the nitric
oxide does originate in the macula densa, it may
play a more generalized permissive or modulatory
role rather than a mediator role. Nevertheless, the
fact that there is abundant nitric oxide synthase in
the macula densa together with our observation
that the activity of this enzyme is apparently
increased by frusemide warrants additional investi-
gation of the role of the macula densa L-arginine-
nitric oxide pathway in the regulation of renin
secretion.
As has been observed by other investigators [29],
frusemide elicited a transient increase in blood
pressure and a prolonged increase in heart rate.
Neither response appears to be due to the accom-
panying increase in renin secretion [29] but, beyond
this, the mechanisms underlying these responses do
not appear to have been identified. It was therefore
of interest that, in the present study, blockade of
nitric oxide synthesis inhibited the heart rate (but
not the pressor) response to frusemide. This finding,
together with evidence that implicates nitric oxide in
the control of heart rate [44-47], suggests that
nitric oxide participates in the heart rate response to
frusemide.
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